Joseph O’Connell
Impact in
- Oncology top 2%
- Colorectal Cancer Treatments and Studies
- Lung Cancer Research Studies
- HER2/EGFR in Cancer Research
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
- Oncology 33
- Colorectal Cancer Treatments and Studies 18
- HER2/EGFR in Cancer Research 12
- Cancer Treatment and Pharmacology 11
-
- Lung Cancer Treatments and Mutations 24
- Gastric Cancer Management and Outcomes 7
- Advanced Breast Cancer Therapies 6
- Co-authors
- Mark G. Kris (10 shared papers)Fergus Shanahan (3 shared papers)Triona Goode (2 shared papers)C. P. Bredin (2 shared papers)Terence M. O’Connor (2 shared papers)Richard J. Gralla (4 shared papers)Ian W. Taylor (11 shared papers)M. S. Wertheim (4 shared papers)
- Journals
- Journal of Clinical Oncology (18 papers)Annals of Oncology (3 papers)Cancer (2 papers)Lung Cancer (2 papers)The Lancet Oncology (2 papers)
- Partner nations
- United StatesSouth KoreaSpain
In The Last Decade
Joseph O’Connell
41 papers receiving 2.4k citations
Joseph O’Connell's Hit Papers
Peers
Comparison fields: 5 of 105
- Oncology 1.3k
- Pulmonary and Respiratory Medicine 1.2k
- Cellular and Molecular Neuroscience 244
- Cancer Research 192
- Sensory Systems 59
Countries citing papers authored by Joseph O’Connell
This map shows the geographic impact of Joseph O’Connell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph O’Connell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph O’Connell more than expected).
Fields of papers citing papers by Joseph O’Connell
This network shows the impact of papers produced by Joseph O’Connell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph O’Connell. The network helps show where Joseph O’Connell may publish in the future.
Co-authors
The 25 scholars most cited alongside Joseph O’Connell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The role of substance P in inflammatory disease Hit paper breakdown → | 2004 | 620 |
| 2 | 1985 | 253 | |
| 3 | 2015 | 221 | |
| 4 | 2012 | 211 | |
| 5 | 1986 | 202 | |
| 6 | 2014 | 120 | |
| 7 | 2014 | 111 | |
| 8 | 2014 | 100 | |
| 9 | Phase I trial of taxol given as a 3-hour infusion every 21 days. | 1986 | 81 |
| 10 | 1987 | 61 | |
| 11 | Phase I trial and clinical pharmacological evaluation of 10-ethyl-10-deazaaminopterin in adult patients with advanced cancer. | 1988 | 51 |
| 12 | 2016 | 49 | |
| 13 | 2010 | 43 | |
| 14 | 1986 | 40 | |
| 15 | 2009 | 36 | |
| 16 | 2010 | 36 | |
| 17 | 1977 | 32 | |
| 18 | 2006 | 30 | |
| 19 | 2016 | 29 | |
| 20 | 2010 | 22 |
About Joseph O’Connell
Joseph O’Connell is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Surgery and Dermatology, having authored 41 papers that have together received 2.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (24 papers), Colorectal Cancer Treatments and Studies (18 papers), HER2/EGFR in Cancer Research (12 papers), Cancer Treatment and Pharmacology (11 papers), Gastric Cancer Management and Outcomes (7 papers), Advanced Breast Cancer Therapies (6 papers), Chemotherapy-related skin toxicity (3 papers) and Statistical Methods in Clinical Trials (3 papers). The work is most often cited by research in Oncology (1.3k citations), Pulmonary and Respiratory Medicine (1.2k citations), Cellular and Molecular Neuroscience (244 citations), Cancer Research (192 citations) and Sensory Systems (59 citations). Joseph O’Connell has collaborated with scholars based in United States, South Korea and Spain. Frequent co-authors include Mark G. Kris, Fergus Shanahan, Triona Goode, C. P. Bredin, Terence M. O’Connor, Richard J. Gralla, Ian W. Taylor, M. S. Wertheim, Pasi A. Jänne and Jane Liang. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer, Lung Cancer and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.